top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. Methods and results We ...

European Heart Journal, Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.

Date : 01/07/2010
Ehjournal

Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned 1504 ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014 Item size : 278462 bytes
Ehjournal

In patients with recently decompensated congestive heart failure (CHF) and depressed LV function, the drug was associated with excess mortality compared with a placebo group. Methods and results We ...

European Heart Journal, Hohnloser, Stefan H., Crijns, Harry J.G.M., van Eickels, Martin, Gaudin, Christophe, Page, Richard L., Torp-Pedersen, Christian, Connolly, Stuart J.

Date : 01/07/2010
Ehjournal

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014